Credit: Canva
Low-dose CT chest scans could help detect pneumonia in at-risk patients while exposing them to only small amounts of radiation, a new study has found. The research, published in Radiology: Cardiothoracic Imaging, shows that ultra-low-dose scans can effectively detect pneumonia in patients with compromised immune systems, enabling doctors to treat the infection before it becomes life-threatening. According to the researchers, these scans expose patients to just 2% of the radiation dose used in a standard CT scan.
"This study paves the way for safer, AI-driven imaging that reduces radiation exposure while preserving diagnostic accuracy,” lead researcher Dr Maximiliano Klug, a radiologist with the Sheba Medical Center in Ramat Gan, Israel, said in a news release. He added that CT scans are the gold standard for detecting pneumonia but there are concerns regarding the risk posed by repeated exposure to radiation. There is a solution- ultra-low-dose CT scan. However, the problem is that these scans can be grainy and hard to read, researchers said.
Study Gives Solution To This
To overcome that, Klug's team developed an AI program that could help "de-noise" low-dose scans, making them sharper and easier to read. Between September 2020 and December 2022, 54 patients with compromised immune systems who had fevers underwent a pair of chest CT scans -- a normal dose scan and an ultra-low-dose scan. The AI program cleaned up the low-dose scan, and then both sets of images were given to a pair of radiologists for assessment. Radiologists had 100% accuracy in detecting pneumonia and other lung problems with the AI-cleaned low-dose scans, but 91% to 98% accuracy in examining the scans that hadn’t been improved through AI, results show.
"This pilot study identified infection with a fraction of the radiation dose," Klug said. "This approach could drive larger studies and ultimately reshape clinical guidelines, making denoised ultra-low dose CT the new standard for young immunocompromised patients.
How Can You Detect Pneumonia?
Pneumonia is a lung infection that causes the air sacs in the lungs to fill with fluid or pus and can be caused by bacteria, viruses, or fungi. The symptoms can range from milk to severe, which includes:
Coughing with or without cough
Fever
Chills
Trouble breathing
Chest pain, especially when breathing deeply or coughing
Sweating or chills
Rapid heart rate
Loss of appetite
Bluish skin, lips, and nails
Confusion.
How to detect Pneumonia in coughing newborns and toddlers?
Pneumonia can severely affect newborns and young children as their lungs are comparatively more sensitive. As per Dr Goyal, young children can cough for various reasons including seasonal infections and tonsillitis, which is very common in this age group. But if they look visibly irritable and have poor sleep patterns, then parents must reach out to an expert. "I am not saying that parents must visit a hospital but any local paediatrician would be able to detect pneumonia in your kid.
Credit: iStock
Ugandan health authorities have confirmed an isolated case of Marburg virus disease (MVD) in a young child who died from the highly infectious viral hemorrhagic fever.
The case comes as Uganda is already battling an outbreak of Ebola virus disease, another viral hemorrhagic fever.
According to the Africa Centres for Disease Control and Prevention (Africa CDC), the Marburg infection was detected during surveillance for the ongoing Ebola outbreak, Reuters reported.
Health officials said no contacts of the child have developed symptoms, and there are currently no active Marburg cases in the East African nation.
While a spokesperson for Uganda's Ministry of Health said they were unaware of a Marburg outbreak, the World Health Organization (WHO) confirmed it was notified of the case on June 30.
"WHO has requested further information and is supporting the local response, including case investigation, active case finding, contact tracing and community engagement," a WHO spokesperson said.
Also read: Scientific Breakthrough: US Scientists Create First Synthetic Cell That Eats and Reproduces
According to Africa CDC, the case was identified in Kyegegwa district in western Uganda in a 1½-year-old child who later died.
"Africa CDC is engaging the Government of Uganda through official public health channels on reports concerning Marburg virus disease. At this stage, we cannot confirm reports of any additional case," Africa CDC spokesperson Saran Koly said.
"Africa CDC stands ready to support verification, risk assessment and response readiness as needed."
Uganda last reported a Marburg outbreak in 2017 and has experience of managing three previous outbreaks. However, responding to a potential Marburg outbreak while simultaneously battling Ebola could complicate public health efforts.
So far, Uganda has reported a total of 20 cases of the rare Bundibugyo species of Ebola, including two deaths. Of these, 15 cases were imported from the Democratic Republic of Congo.
The child's age has prompted questions about how the infection occurred. Abraar Karan, a global health physician and researcher at Stanford University, said infection in a toddler is unusual.
"Quite unusual -- I would suspect transmission from someone else, but there are some less-likely scenarios in which spillover could still have happened directly to a toddler," he wrote in a post on X.
Read More: WHO Issues First Clinical Care Guidelines On Ebola And Marburg Disease
Marburg virus disease belongs to the same virus family as Ebola and can cause severe hemorrhagic fever. It was first recognized in 1967. MVD has a high case fatality rate ranging from 32 per cent to 88 per cent. It is transmitted to humans after a spill-over event from a wildlife reservoir such as Rousettus aegyptiacus fruit bats or their feces or contact with infected primates
Once a person is infected, the virus spreads through direct contact with the blood, bodily fluids or contaminated materials of an infected person.
Common Signs and Symptoms
Symptoms usually begin suddenly and include:
In severe cases, patients may develop internal and external bleeding, organ failure and shock, which can be fatal.
There is currently no approved vaccine or specific treatment for Marburg virus disease, although several vaccines and therapies are under development. Early supportive care can improve survival.
Health authorities recommend:
Credit: Adamala Lab
What sounds like science fiction is now a scientific reality. Researchers at the University of Minnesota have created the world's first synthetic cell built entirely from non-living chemical components that can eat, grow and reproduce—the defining characteristics of life.
The lab-made cell, named SpudCell, completes an entire life cycle and could help scientists better understand how life works while opening new possibilities in medicine, biotechnology and manufacturing.
"We've replicated in chemistry what only used to be possible in biology: the complete set of behaviors of a cell," said Associate Professor Kate Adamala. "It proves that the most fundamental functions of life... do not need a mysterious, magical spark."
The findings have been published as a preprint and have not yet been peer-reviewed.
"We have demonstrated key milestones towards construction of synthetic life: a complete cell cycle, including growth and division, and selection, in minimal cells with known identity of all components. This can serve as a chassis for further optimization of synthetic cells undergoing Darwinian evolution, advancing the field towards robust artificial life," the researchers wrote.
SpudCell is a synthetic cell assembled entirely from purified, non-living chemical components rather than modified living cells.
It contains:
Replicate a Cell's Life Cycle
SpudCell can perform the essential functions of living cells, including:

Unlike natural cells, SpudCell divides without a cytoskeleton. Instead, membrane-binding proteins build up on its surface until mechanical stress causes the membrane to split.
Researchers also engineered a faster-growing version of the cell. Within five generations, it outcompeted the original, demonstrating selection and evolution-like behaviour in a fully synthetic chemical system.
Scientists previously estimated that the smallest possible genome for a living cell would be around 113 kilobase pairs (kbp). SpudCell functions with just 90 kbp, making it one of the simplest known cell-like systems.
Its modular DNA design also allows researchers to program different cellular functions independently, making future synthetic cells easier to engineer.
Researchers stated that synthetic cells could eventually perform chemical reactions beyond the reach of conventional industrial processes.
Possible applications include:
"We could see materials that are grown, rather than synthesized... SpudCell provides, for the first time, a truly engineerable platform," the authors said.
The researchers noted that in next steps they aim to combine the cell's multiple DNA molecules into a single stable genome, add more molecular machinery and develop common engineering standards before synthetic cells can be widely used.
"This work is just the beginning," Adamala said. "We are showing it's possible to engineer the basic functions of the cell."
While calling the work remarkable, Professor John Dupré of the University of Exeter questioned whether synthetic cells would outperform genetically modified bacteria in producing drugs, food, fuel and other materials.
He also argued that synthetic cells lack an important feature of living organisms—their relationships with other life forms.
"What is missing... is the relational aspect of life, which has become clear in the growing realization that life is almost universally symbiotic," he said.
Credit: AI-generated image
An 11-year-old boy in Canada succumbed to rabies after waking up to find a bat on his face. The incident highlighted how even seemingly harmless contact with the animal, with no bites, can lead to a fatal infection if preventive treatment is not started in time, which is crucial in rabies.
The case was published in the Canadian Medical Association Journal (CMAJ). The incident occurred during the summer of 2024 while the boy was staying at a cottage in northern Ontario.
According to the report, he woke up with a bat on his face and instinctively swatted it away. His father caught the bat in a cooking pot and released it outdoors. Since there were no visible bite or scratch marks and the bat did not appear to behave aggressively, the family did not suspect rabies and seek medical attention.
However, 19 days later, the child developed facial tingling and numbness, followed by swelling, vomiting, and loss of appetite.
He was treated for a suspected viral infection initially, but his condition rapidly worsened. He went on to develop difficulty swallowing, fever, slurred speech, confusion, and visual hallucinations before being diagnosed with rabies. Despite being admitted in pediatric intensive care, he died after 17 days of admission.
Also read: The Lancet: Young Adults With Obesity Face Higher Heart Risk; Statins Benefit Older Adults
The authors of the case report said the family agreed to share the child's story to raise awareness about rabies and the importance of seeking immediate medical evaluation after any direct contact with a bat, even if there are no visible bite marks.
Because of this, public health authorities recommend seeking medical advice after direct contact with a bat.
Also read: Illinois Governor Claims Trump Continues To Suffer From Dementia
Immediate treatment with rabies vaccination is highly effective in preventing the disease if administered before symptoms develop. Once rabies symptoms appear, it is almost always fatal.
Human rabies cases are rare in Canada. Since 1924, only 28 human rabies cases have been reported in the country, and the Ontario child's death marked the province's first human rabies case since 1967.
While dogs remain the primary source of human rabies' deaths globally, bats are the leading source of human rabies infections acquired in North America.
According to the World Health Organization, rabies causes an estimated 59,000 human deaths every year, with the vast majority occurring in Asia and Africa.
The authors of the CMAJ case report stressed that healthcare providers should carefully assess any history of direct bat contact and consider post-exposure prophylaxis when appropriate.
They noted that early treatment is nearly 100% effective in preventing rabies before symptoms begin, making timely medical evaluation critical after any potential exposure.
© 2024 Bennett, Coleman & Company Limited